Ocu-Pentolate

• Antimuscarinic eye preparations
• Muscarinic Antagonists
• Mydriatics
• Parasympatholytics
• ATC:S01FA04

• AK-Pentolate
• Akpentolate
• Ciclopentolato [INN-Spanish]
• Cyclogyl
• Cyclopentoiate
• Cyclopentolate HCL
• Cyclopentolatum [INN-Latin]
• Cyclopentylate
• Cylate
• Diopentolate
• Minims Cyclopentolate
• Mydrilate
• Ocu-Pentolate
• Pentolair
• yclopentolate

• No information avaliable

C₁₇H₂₅NO₃

No information avaliable

Ocu-Pentolate MSDS

No information avaliable

291.385 g/mol

139 ^oC (hydrochloride salt)

No information avaliable

Solid

3.124

Ophthalmic solution (eye drops)

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Absorbed following ophthalmic administration.

Oral LD₅₀ in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

No information avaliable

Humans and other mammals